
Atalanta
Atalanta was created to address the urgent global need for interventions to treat neurodegenerative diseases.
Series B+ ·
Amount not disclosed in a source on record.
Funding history ↓Signals
Website registeredMay 8, 2019 (7 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | undisclosed | — | fundraisingfox.com |
Timeline
- Website created
Companies like Atalanta
AAstrocyte Pharmaceuticals$9.5M Series B+ · Sep 2026
CCanopie$3.7M Seed · Sep 2024DDITTO DailySeed · Jul 2026
SSeragy$13.43M · Oct 2026
NNRG Therapeutics$67M Series B+ · Sep 2025
PPhotopharmics$6M Series B+ · Apr 2025
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/atalanta (get a free API key).